First-Line Antihypertensive Regimen Selection
For most adults with hypertension, initial therapy should be a thiazide-type diuretic, ACE inhibitor/ARB, or calcium channel blocker, with specific selection based on race and comorbidities—particularly, Black patients without heart failure or chronic kidney disease should start with a thiazide-type diuretic or calcium channel blocker. 1
General Population Approach
Non-Black Patients
- Start with low-dose ACE inhibitor or ARB as first-line monotherapy 1, 2
- If blood pressure remains uncontrolled, add a dihydropyridine calcium channel blocker (DHP-CCB) 1
- Increase to full dose before adding additional agents 1
- Third-line: add a thiazide or thiazide-like diuretic 1, 2
Black Patients Without Heart Failure or CKD
- Initial treatment must include either a thiazide-type diuretic OR a calcium channel blocker 1
- These agents are significantly more effective than ACE inhibitors or ARBs as monotherapy in Black patients 1, 3
- Preferred initial regimen: low-dose ARB combined with DHP-CCB or thiazide/thiazide-like diuretic 1, 3
- ACE inhibitors like benazepril are less effective as monotherapy in this population 3
- Black patients have 1.3-times greater risk of nonfatal stroke, 1.8-times greater risk of fatal stroke, and 4.2-times greater risk of end-stage renal disease, making appropriate initial therapy critical 1
Dosing Specifications
Thiazide Diuretics
- Hydrochlorothiazide: 25-50 mg daily for optimal blood pressure control in Black patients 3
- Chlorthalidone: 12.5-25 mg daily for endpoint protection 1
- Lower doses are either unproven or less effective in clinical outcome trials 1
Combination Therapy Requirements
- Two or more antihypertensive medications are required to achieve BP target <130/80 mmHg in most adults, especially Black adults 1
- Single-pill combinations improve adherence and are particularly effective when including either a diuretic or CCB 3
- Consider monotherapy only in low-risk grade 1 hypertension, patients aged >80 years, or frail patients 1
Age-Specific Considerations
Adults Under 65 Years
Adults 65 Years and Older
- Target systolic blood pressure: <130 mmHg 2
- May consider monotherapy if frail 1
- Individualize based on frailty status 1
Comorbidity-Driven Selection
Diabetes Mellitus
- Target BP: <130/80 mmHg 1
- Black patients with diabetes: thiazide-type diuretic or CCB remains first-line 1
- ACE inhibitors or ARBs provide additional renal protection but should be combined with diuretic or CCB in Black patients 1
Chronic Kidney Disease
- Target BP: <130/80 mmHg 1
- ACE inhibitors or ARBs are indicated as part of the regimen despite reduced efficacy as monotherapy in Black patients 3
- Combination with CCB or thiazide diuretic produces similar BP lowering across all racial groups 1, 3
Heart Failure
- ACE inhibitors or ARBs become first-line regardless of race 1
- Beta-blockers are indicated in this specific setting 1
Critical Safety Considerations
Race-Specific Adverse Effects
- Black patients have greater risk of angioedema with ACE inhibitors compared to other racial groups 3
- This represents an important safety consideration when selecting renin-angiotensin system inhibitors 3
Combination Therapy Cautions
- Use initial combined therapy cautiously in patients at risk of orthostatic hypotension 1
- Avoid combining ACE inhibitors with ARBs—this combination is not recommended 1
Treatment Escalation Algorithm
Stage 1 Hypertension (140-159/90-99 mmHg)
- High-risk patients (CVD, CKD, diabetes, organ damage): start drug treatment immediately 1
- Low-moderate risk patients: start lifestyle interventions, add drug treatment if BP remains elevated after 3-6 months 1
Stage 2 Hypertension (≥160/100 mmHg)
- Start drug treatment immediately with two-drug combination for most patients 1
- Usual combination: thiazide-type diuretic plus ACE inhibitor, ARB, or CCB 1
Resistant Hypertension (Uncontrolled on 3 Drugs)
- Add spironolactone as fourth-line agent 1
- Alternatives if spironolactone not tolerated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker 1
Monitoring Timeline
- Achieve target blood pressure within 3 months of initiating therapy 1, 3
- Minimum BP reduction goal: 20/10 mmHg even if target not fully achieved 1
- Use home BP monitoring to confirm office readings (home BP ≥135/85 mmHg indicates hypertension) 1
Common Pitfalls to Avoid
- Do not use ACE inhibitors or ARBs as monotherapy in Black patients without heart failure or CKD—they are significantly less effective 1, 3
- Do not underdose thiazide diuretics—hydrochlorothiazide 12.5 mg is insufficient; use 25-50 mg 1, 3
- Do not use beta-blockers as first-line therapy unless specific compelling indication exists (heart failure, post-MI) 1, 2
- Despite guidelines, many older Black adults continue to be initiated on non-recommended first-line agents, representing a significant quality gap 4